Skip to content

Smokefree and MS - Feasibility study for the conduction of a tailored smoking cessation programm for people with Mutliple Sclerosis

Smokefree and MS - Feasibility study for the conduction of a tailored smoking cessation programm for people with Mutliple Sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035557
Enrollment
60
Registered
2024-12-09
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35

Interventions

Group 1: The study includes five online group sessions for all participants (approximately 90 minutes each) over a period of three weeks. Each group consists of up to ten participants. Between the thi

Sponsors

Universitätsklinikum Hamburg-Eppendorf, Institut für Neuroimmunologie und Multiple Sklerose
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: MS diagnosis Current smoker of tobacco cigarettes Internet access

Exclusion criteria

Exclusion criteria: not of age no MS diagnosis only using e-cigarettes, vapes or heated tobacco products

Design outcomes

Primary

MeasureTime frame
Demand: Recruitment duration; number of participants who consented; number of participants who withdrew or were lost to follow-up Practicality: Number of participants with complete baseline, and follow-up data Acceptability: System Usability Scale (SUS), Theoretical Framework of Acceptability Questionnaire (TFA), Self-developed Acceptability Questionnaire

Secondary

MeasureTime frame
Smoking status, Fagerström test of nicotine dependence, cotinine in salvia sample

Countries

Germany

Contacts

Public ContactAlex Maximilian Keller

Universitätsklinikum Hamburg-Eppendorf

al.keller@uke.de+49 40 7410 57354

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026